MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The mitochondrial risk score and lifestyle factors are associated with age at onset in LRRK2 p.Gly2019Ser Parkinson’s disease.

T. Lüth, C. Gabbert, P. Lajer, I. König, A. Caliebe, S. Koch, B-H. Laabs, F. Hentati, S. Sassi, R. Amouri, C. Klein, A. Grünewald, M. Farrer, J. Trinh (Lübeck, Germany)

Meeting: 2022 International Congress

Abstract Number: 1303

Keywords: Leucine-rich repeat kinase 2(LRRK2), Mitochondrial dysfunction, Parkinson’s

Category: Parkinson's Disease: Genetics

Objective: To investigate the relationship between a mitochondrial risk score (MRS), lifestyle and age at onset (AAO) in LRRK2 G2019S Parkinson’s disease (PD).

Background: PD is the fastest growing neurological disorder worldwide, and the p.Gly2019Ser mutation in the Leucine-rich repeat kinase 2 (LRRK2) gene is the most common cause for monogenic PD. The penetrance among LRRK2 p.Gly2019Ser mutation carriers is highly age-dependent, and the mechanisms behind disease onset are poorly understood. Genetic, environmental, and lifestyle factors can affect the manifestation of PD. Specifically, mitochondrial DNA damage has been shown to influence the penetrance of LRRK2 p.Gly2019Ser PD.

Method: In our study, we included 486 patients with PD carrying an LRRK2 p.Gly2019Ser mutation from three cohorts: Fox Insight (N=154), AMP-PD (N=127) and a cohort recruited from the Tunisian Arab Berber population (N=205). Genotypes were obtained from genome arrays and whole-genome sequencing data. Mitochondrial polygenic risk score analysis was performed based on a previously published list of genes associated with mitochondrial function that influences PD risk, nominated by a Mendelian randomization study. In addition, lifestyle factors were assessed with the PD risk factor questionnaire (PD-RFQ). Relationships were estimated by linear regression models where the self-declared AAO was used as an outcome.

Results: For patients with LRRK2 p.Gly2019Ser PD, the MRS was associated with AAO (p=4.11×10-4, β=-66.02, SE=18.56). The higher the MRS, the earlier the AAO. In contrast, the lifestyle factors smoking (p=0.03, β=4.40, SE=1.95) and black tea consumption (p=0.04, β=3.99, SE=1.97) were associated with later AAO. No interaction was found between the MRS and the investigated lifestyle factors. However, when including both lifestyle factors and MRS in the model, the association between MRS and AAO dissipated.

Conclusion: Our data suggest that risk variants within genes associated with mitochondrial function, smoking, and black tea consumption affect the AAO in LRRK2 p.Gly2019Ser mutation carriers. No interaction between lifestyle factors and MRS was apparent. The results highlight the importance of investigating the underlying molecular mechanism and the potential interplay between genetics, environment, and lifestyle.

To cite this abstract in AMA style:

T. Lüth, C. Gabbert, P. Lajer, I. König, A. Caliebe, S. Koch, B-H. Laabs, F. Hentati, S. Sassi, R. Amouri, C. Klein, A. Grünewald, M. Farrer, J. Trinh. The mitochondrial risk score and lifestyle factors are associated with age at onset in LRRK2 p.Gly2019Ser Parkinson’s disease. [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/the-mitochondrial-risk-score-and-lifestyle-factors-are-associated-with-age-at-onset-in-lrrk2-p-gly2019ser-parkinsons-disease/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-mitochondrial-risk-score-and-lifestyle-factors-are-associated-with-age-at-onset-in-lrrk2-p-gly2019ser-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley